NCT06606210View on ClinicalTrials.gov

INNOVEN: Efficacy of Porcine Placental Extracellular Matrix Plus Standard of Care (SOC) Versus SOC Alone

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

September 19, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

April 30, 2026

Conditions
Wound HealVenous Leg Ulcer
Interventions
DEVICE

InnovaMatrix® AC

Weekly dressing applications

Trial Locations (1)

34289

RECRUITING

Three Rivers Wound and Hyperbaric Center, North Port

Sponsors

Lead Sponsor

ConvaTec Inc.
All Listed Sponsors
lead

ConvaTec Inc.

INDUSTRY

NCT06606210 - INNOVEN: Efficacy of Porcine Placental Extracellular Matrix Plus Standard of Care (SOC) Versus SOC Alone | Biotech Hunter | Biotech Hunter